MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-49 Cr | ₹-141 Cr | ₹-259 Cr | ₹-84 Cr | ₹-45 Cr |
What is the latest Cash Flow from Investing Activities ratio of MARKSANS PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-49 Cr |
| Mar2024 | ₹-141 Cr |
| Mar2023 | ₹-259 Cr |
| Mar2022 | ₹-84 Cr |
| Mar2021 | ₹-45 Cr |
How is Cash Flow from Investing Activities of MARKSANS PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-49 Cr | Negative | |
| Mar2024 | ₹-141 Cr | Negative | |
| Mar2023 | ₹-259 Cr | Negative | |
| Mar2022 | ₹-84 Cr | Negative | |
| Mar2021 | ₹-45 Cr | - | |
Compare Cash Flow from Investing Activities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,205.2 Cr | -3.2% | 4.9% | -29% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -3.2% |
4.9% |
-29% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses